Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2025 ,inter alia, to consider and approve the unaudited standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions Limited has informed BSE that its Board of Directors will meet on Friday, 18 July 2025. The agenda, among other items, is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 (Q1 FY26). The intimation is being made under Regulation 29 of the SEBI Listing Regulations. The filing is signed by Managing Director Brahma Gurbani. No financial numbers or performance details have been disclosed in this filing — those will come after the board meeting.
This is a routine regulatory intimation and does not contain any business or financial information. Shareholders should wait for the actual Q1 FY26 results to be published on or after 18 July 2025 to assess the company's performance.